Onderneming Protagenic Therapeutics, Inc.
Aandelen
PTIX
US74365N2027
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,3 USD | -5,58% | -20,63% | +31,31% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alexander Arrow
DFI | Director of Finance/CFO | 53 | 01-02-16 |
Andrew Slee
COO | Chief Operating Officer | 74 | 01-02-16 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 12-02-16 |
Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Garo Armen
FOU | Founder | 71 | 03-02-94 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 12-02-16 |
Brian Corvese
BRD | Director/Board Member | 67 | 28-07-17 |
Khalil Barrage
BRD | Director/Board Member | 59 | 01-07-07 |
Timothy Wright
BRD | Director/Board Member | 66 | 23-11-22 |
Jennifer Buell
BRD | Director/Board Member | 50 | 18-07-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 4 435 132 | 3 466 915 ( 78,17 %) | 0 | 78,17 % |
Bedrijfsgegevens
Protagenic Therapeutics, Inc.
149 Fifth Avenue Suite 500
10010, New York
+212 994 8200
http://www.protagenic.comSector
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+31,31% | 5,77 mln. | |
+0,67% | 42,4 mld. | |
+44,30% | 40,04 mld. | |
-6,20% | 28,31 mld. | |
+6,55% | 24,94 mld. | |
-21,66% | 18,96 mld. | |
+29,96% | 12,3 mld. | |
-1,57% | 11,95 mld. | |
+16,03% | 11,32 mld. | |
-4,80% | 11,55 mld. |
- Beurs
- Aandelen
- Koers PTIX
- Onderneming Protagenic Therapeutics, Inc.